BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 29, 2007
View Archived Issues
Insomnia: Clinical results of drugs under active development
Read More
Natural product shows in vitro potential to prevent diabetic cataract
Read More
Recent patents impart new therapeutics for respiratory and allergic disorders
Read More
Surface Logix new ROCK-2 inhibitor reduces kidney fibrosis in vivo
Read More
Recent patents disclose novel antiinfective agents
Read More
Positive preclinical assessment for the antidiabetic compound LY-2463665
Read More
Positive results for Theravance's phase II study of TD-5108
Read More
DelSite provides update on GelVac
Read More
Plethora completes patient enrollment for phase II study of PSD-597
Read More
Abbott and Genentech collaborate on oncology compounds
Read More
Advancis reports on FDA review of phase III trial design of Keflex PULSYS
Read More
BFTP/SEP continues funding of Immunotope cancer vaccine
Read More
Ipsen enters agreement with PregLem to develop reproductive medicines
Read More
SurModics and Merck & Co. sign ophthalmic license and research collaboration
Read More
Novel therapeutic agents for cardiovascular disorders imparted in recent patents
Read More
New phase II trial evaluates SCV-07 for HCV
Read More
Vasogen receives FDA guidance on Celacade program
Read More
UK-421045 selected for preclinical evaluation as topical antiscarring agent
Read More
Dade Behring grants sublicense to Beckman Coulter on cardiac markers
Read More
Phase II program begins for sufentanil patch
Read More
Aastrom's adult stem cell trial in critical limb ischemia begins treatment
Read More
Swedish clearance for phase III trial of K-101 for onychomycosis
Read More
Randomization targets met in two phase III trials of corifollitropin alfa
Read More
New formulation of Rebif recommended for European approval
Read More
Fertility treatment Pergoveris approved in E.U.
Read More
Supplemental NDA filed for Metvixia
Read More